Unbound MEDLINE

Articles related to 18559790 journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:Bookmark this site
Articles related to 18559790 [Unique ID], provided by the PubMed system
1 - 10 of 102 journal articles in the PubMed databaseEmail to a friend    
 
Kong HH, Sibaud V, Chanco Turner ML, et al. 
Sorafenib-induced eruptive melanocytic lesions. [Case Reports, Letter]
Arch Dermatol 2008 Jun; 144(6):820-2.
Full Citation | Publisher Full Text | Find Related Articles 
Hong DS, Reddy SB, Prieto VG, et al. 
Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. [Case Reports, Journal Article, Research Support, N.I.H., Extramural]
Arch Dermatol 2008 Jun; 144(6):779-82.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Lai SE, Kuzel T, Lacouture ME 
Hand-foot and stump syndrome to sorafenib. [Case Reports, Journal Article]
J Clin Oncol 2007 Jan 20; 25(3):341-3.
Full Citation | Publisher Full Text | Find Related Articles 
Autier J, Escudier B, Wechsler J, et al. 
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Arch Dermatol 2008 Jul; 144(7):886-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Beldner M, Jacobson M, Burges GE, et al. 
Localized Palmar Plantar Epidermal Hyperplasia: A Previously Undefined Dermatologic Toxicity to Sorafenib. [JOURNAL ARTICLE]
Oncologist 2007; 12(10):1178-1182.
Abstract | Full Citation
Lountzis NI, Maroon MS 
Sorafenib-induced palmoplantar hyperkeratosis. [Journal Article]
J Drugs Dermatol 2008 Jun; 7(6):588-9.
Abstract | Full Citation | Find Related Articles 
Ratain MJ, Eisen T, Stadler WM, et al. 
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. [Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 2006 Jun 1; 24(16):2505-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Yang CH, Lin WC, Chuang CK, et al. 
Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. [JOURNAL ARTICLE]
Br J Dermatol 2007 Dec 6.
Abstract | Full Citation | Find Related Articles 
Bhojani N, Jeldres C, Patard JJ, et al. 
Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma. [JOURNAL ARTICLE]
Eur Urol 2007 Nov 26.
Abstract | Full Citation | Find Related Articles 
New Search Next Results
  
Medical References for Treo, iPhone or Blackberry!

Advertise on this site.